Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 29,403 | -84,134 | -102,562 | -92,189 | -74,375 |
| Depreciation Amortization | 9,326 | 10,247 | 7,481 | 9,613 | 5,033 |
| Accounts receivable | -1,603 | -6,671 | 4,838 | -2,012 | -6,176 |
| Accounts payable and accrued liabilities | -5,072 | 1,713 | -2,239 | 764 | 3,402 |
| Other Working Capital | -3,286 | -3,004 | 5,665 | -6,026 | -18,002 |
| Other Operating Activity | -9,265 | 3,537 | 20,387 | 22,332 | 22,189 |
| Operating Cash Flow | $19,503 | $-78,312 | $-66,430 | $-67,518 | $-67,929 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -218,283 | 64,883 | -36,561 | 8,843 | -6,667 |
| PPE Investments | -1,039 | -2,836 | -1,854 | -10,392 | -8,197 |
| Investing Cash Flow | $-219,322 | $62,047 | $-38,415 | $-1,549 | $-14,864 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -16,000 | N/A | N/A | -4,500 | N/A |
| Common Stock Issued | 233,839 | 8,548 | 107,182 | 73,309 | 65,929 |
| Other Financing Activity | 34,000 | 18,000 | 0 | 0 | 0 |
| Financing Cash Flow | $251,839 | $26,548 | $107,182 | $68,809 | $65,929 |
| Beginning Cash Position | 33,927 | 23,644 | 21,307 | 21,265 | 33,629 |
| End Cash Position | 85,947 | 33,927 | 23,644 | 21,007 | 16,765 |
| Net Cash Flow | $52,020 | $10,283 | $2,337 | $-258 | $-16,864 |
| Free Cash Flow | |||||
| Operating Cash Flow | 19,503 | -78,312 | -66,430 | -67,518 | -67,929 |
| Capital Expenditure | -1,039 | -2,836 | -1,854 | -10,433 | -8,207 |
| Free Cash Flow | 18,464 | -81,148 | -68,284 | -77,951 | -76,136 |